2022. Drugs in the COVID-19 pandemic: Analysis of the commercialization of azithromycin, hydroxychloroquine, ivermectin and nitazoxanide in Brazil. Research, Society and Development. 11, 6 (Apr. 2022), e16711628726. DOI:https://doi.org/10.33448/rsd-v11i6.28726.